-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – rencofilstat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry rencofilstat Drug Details Rencofilstat (CRV-431) is under development for the treatment of hepatitis C...
-
Product Insights
Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Shingles (herpes zoster) is caused by the varicella-zoster virus. Symptoms may include fever and chills, headache, joint pain, and swollen glands. The predisposing factors include age and a weakened immune system. The Herpes Zoster (Shingles) pipeline drugs market research report provides an overview of the Herpes Zoster (Shingles) (Infectious Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Herpes Zoster (Shingles) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action...
-
Sector Analysis
The Global Military Simulator Systems Market to 2030
The Global Military Simulator Systems Market to 2030 report provides the market size forecast and the projected Compound Annual Growth Rate (CAGR) for the next ten years. The report covers the industry analysis including the key market drivers, emerging technology trends, and major challenges faced by industry participants. It also offers insights regarding key factors and government programs that are expected to influence the demand for military simulator systems market over the forecast period. The demand for military simulator systems...